abmart-banner
Global R&D Pipeline
My Favorite
Hot Targets:
Home>AbMart>

Global R&D Pipeline

ACKR3
Back
Total number of drugs
19
Phase II and later clinical stages
5.3%
Involving companies
22
Main therapeutic areas
Other Diseases
Data Table
Data Chart
Select Row
Fixed Column
Download Table
Molecule Info
R&D and Market Info
ADC Info
DrugDrug Name EnDrug TypeTreatment FieldMechanism of ActionOriginatorDeveloperIndicationHighest Development StageHighest Development Stage (China)Approved Countries/RegionsApproved TimeApproved Time (China)Special ReviewADC TypeADC LinkerADC PayloadADC DARDrug NameAntibody TypeADC Linking SiteOperation
TC-14012TC-14012Synthetic peptideNeoplasms Immune System Diseases Infectious Diseases Respiratory Diseases Urogenital Diseasesatypical chemokine receptor 3 agonists C-X-C motif chemokine receptor 4 antagonistsKyoto UniversityPeking UniversityUniversity of MontréalKyoto UniversityPreclinicalPreclinicalTC-14012
detail  >
CCX-650CCX-650Small molecule drugOther Diseasesatypical chemokine receptor 3 inhibitorsChemoCentryx, Inc.DiscoveryCCX-650
detail  >
WO2026051808WO2026051808Small molecule drugDigestive System Disorders Respiratory Diseases Urogenital Diseases Other Diseasesatypical chemokine receptor 3 agonistsSichuan UniversitySichuan UniversityDiscoveryWO2026051808
detail  >
WO2025196057WO2025196057Small molecule drugNeoplasms Nervous System Diseases Cardiovascular Diseases Endocrinology and Metabolic Disease Hemic and Lymphatic Diseases Urogenital Diseases Other Diseasesatypical chemokine receptor 3 modulatorsLuxembourg Institute of HealthLuxembourg Institute of HealthDiscoveryWO2025196057
detail  >
WO2023166190WO2023166190Small molecule drugNeoplasms Immune System Diseases Nervous System Diseases Other Diseasesatypical chemokine receptor 3 modulatorsInterAx Biotech AGInterAx Biotech AGDiscoveryWO2023166190
detail  >
CN117143821CN117143821Mesenchymal stem cell therapyRespiratory Diseases Other DiseasesThe 309th Hospital of Chinese Peoples Liberation ArmyThe 309th Hospital of Chinese Peoples Liberation ArmyDiscoveryCN117143821
detail  >
ACKR3 agonists(Eberhard Karls Universität Tübingen)ACKR3 agonists(Eberhard Karls Universität Tübingen)Small molecule drugCardiovascular Diseasesatypical chemokine receptor 3 agonistsEberhard Karls Universität TübingenEberhard Karls Universität TübingenDiscoveryACKR3 agonists(Eberhard Karls Universität Tübingen)
detail  >
VUN-701VUN-701Nanobodyatypical chemokine receptor 3 inhibitorsMedical College of WisconsinMedical College of WisconsinPreclinicalVUN-701
detail  >
VUF11207VUF11207Small molecule drug Liposomal DrugNeoplasms Nervous System Diseases Other Diseasesatypical chemokine receptor 3 agonistsNational Health Research InstitutesNational Health Research InstitutesPreclinicalVUF11207
detail  >
VUF-15485VUF-15485Chemical drugsNeoplasmsatypical chemokine receptor 3 agonistsVrije Universiteit AmsterdamVrije Universiteit AmsterdamPreclinicalVUF-15485
detail  >
Total 19 data
1
2